Humira Star Still Shines Bright In Abbott’s Sky, Despite Tough Economy

Sales of Abbott's multi-faceted biologic Humira seem to be going from strength to strength, unencumbered by the economic turmoil even though it's an expensive biologic in highly competitive markets

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet